Lilly sandwiches in on Merck, BMS PD-1 competition
This article was originally published in Scrip
Executive Summary
Lilly has entered into separate collaborations with two other big pharmas – Merck and Bristol-Myers Squibb – to test combinations of drugs against various forms of cancer.